Form 8-K - Current report:
SEC Accession No. 0001906324-25-000150
Filing Date
2025-08-05
Accepted
2025-08-05 16:11:59
Documents
15
Period of Report
2025-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K qdel-20250805.htm   iXBRL 8-K 31367
2 EX-99.1 qdel6292025ex991earningsre.htm EX-99.1 399878
7 GRAPHIC qographica.jpg GRAPHIC 11636
  Complete submission text file 0001906324-25-000150.txt   616363

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20250805.xsd EX-101.SCH 2145
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20250805_def.xml EX-101.DEF 14443
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20250805_lab.xml EX-101.LAB 25398
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20250805_pre.xml EX-101.PRE 15018
17 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20250805_htm.xml XML 2704
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 8-K | Act: 34 | File No.: 001-41409 | Film No.: 251185098
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)